NEW YORK – Duality Technologies said Monday that it has been awarded a $1 million contract from the US Defense Advanced Research Projects Agency (DARPA) to develop machine-learning technology for researching genomic susceptibility to COVID-19.
A key feature of the technology is that it must preserve individual privacy while using encrypted data from multiple sources, the Newark, New Jersey-based company said. To this end, Duality will apply homomorphic encryption, a method of encoding data as ciphertext to allow computation without decryption, to the data.